Traduction de «stroke in patients with non-valvular » (Néerlandais → Français) :

Aguilar MI, Hart R. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database of Systematic Reviews 2005, Issue.
Cochrane Database of Systematic Reviews 2011, Issue 12.

Aguilar MI, Hart R. Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.
Search Date February 2009. [http ...]

al. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack.
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack.

Idées-Forces tirées de la revue Prescrire jusqu’au n° 341 (mars 2012). [http ...]
Idées-Forces tirées de la revue Prescrire jusqu’au n° 341 (mars 2012). [http ...]

Olesen JB, Lip GYH, Hansen ML et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study.
Lip GYH, Nieuwlaat R, Pisters R et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation.

Friberg L, Rosenqvist M, Lip GY. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
Olesen JB, Lip GYH, Hansen ML et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study.

Garcia D en Hylek E: Stroke prevention in elderly patients with atrial fibrillation.
Garcia D et Hylek E: Stroke prevention in elderly patients with atrial fibrillation.

Dunn A. Oral anticoagulant therapy safely prevented stroke in older patients with atrial fibrilllation.
Singer DE, Chang Y, Fang MC et al. The net clinical benefit of warfarin anticoagulation in atrial fibrillation.

AIN457 Non-infectious uveitis 2011 III - Phase III study examining AIN457 for non-infectious uveitis in patients with Behcet’s disease did not meet its primary endpoint and the data do not support submission of AIN457 for this indication; based upon analysis of these data, Novartis will stop the extension study in Behcet’s uveitis
Indication potentielle/ Projet / domaine Soumissions Phase Mises à jour molécule thérapeutique prévues actuelle AIN457 Uveitis non infectieuse 2011 III - L’étude de phase III examinant AIN457 contre l’uveitis non infectieuse chez les patients atteints de la maladie de Behcet n’a pas satisfait au critère principal et les résultats sont insuffisants pour justifier le dépôt d’une demande d’autorisation pour cette indication, Novartis arrêtera l’extension de cette étude à l’uveitis de Behcet

The Phase III study evaluating AIN457 for non-infectious uveitis in patients with Behcet’s disease did not meet its primary endpoint and the data do not support submission of AIN457 for this indication.
L’étude de phase III évaluant AIN457 contre l’uveitis non infectieuse chez les patients atteints de la maladie de Behcet n’a pas satisfait au critère principal et les résultats sont insuffisants pour justifier le dépôt d’une demande d’autorisation pour cette indication.